Athersys Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
138.58 M |
Public Float |
115.06 M |
Athersys Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.19 |
Market Cap |
$242.64 M |
Shares Outstanding |
149.78 M |
Public Float |
122.49 M |
Address |
3201 Carnegie Avenue Cleveland Ohio 44115 United States |
Employees | - |
Website | http://www.athersys.com |
Updated | 07/08/2019 |
Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. |